Skip to main content

View full-text article in PMC

. 2014 May 14;20(18):5353–5362. doi: 10.3748/wjg.v20.i18.5353

Table 4.

Comparison of human immunodeficiency virus+ vs human immunodeficiency virus- patients transplanted for hepatocellular carcinoma

Series	Pts number		Milan out		Alfa fetoprotein pre-LT		MiV+		HCC recurrence		Disease free survival (mo)
Series	HIV+	HIV-	HIV+	HIV-	HIV+	HIV-	HIV+	HIV-	HIV+	HIV-	HIV+	HIV-
Di Benedetto et al[48]	30	125	26.7%	43.2%	157.88	327.64	23.30%	16%	6.7%	14.4%	31.7	29.8
Di Benedetto et al[48]	30	125	26.7%	43.2%	(1-2882)	(1-22455)	23.30%	16%	6.7%	14.4%	(1.28-68.78)	(0.43-75.79)
Viber et al[49]	16	58	31%	34%	16	13	50%	43%	31%	15%	27	27
Viber et al[49]	16	58	31%	34%	(3-7154)	(1-552)	50%	43%	31%	15%	(14-79)	(2-78)

MiV+: Microvascular invasion present; HCC: Hepatocellular carcinoma; LT: Liver transplantation; HIV: Human immunodeficiency virus.